These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3435703)

  • 1. Cytokinetic factors in drug resistance of Lewis lung carcinoma: comparison of cells freshly isolated from tumours with cells from exponential and plateau-phase cultures.
    Finlay GJ; Wilson WR; Baguley BC
    Br J Cancer; 1987 Dec; 56(6):755-62. PubMed ID: 3435703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel carbamate analogues of amsacrine with activity against non-cycling murine and human tumour cells.
    Finlay GJ; Holdaway KM; Baguley BC
    Cancer Chemother Pharmacol; 1994; 34(2):159-65. PubMed ID: 8194167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of CI-921, an analogue of amsacrine, on advanced Lewis lung tumours in mice: relevance to clinical trials.
    Baguley BC; Calveley SB; Harvey VJ
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):211-8. PubMed ID: 3356209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of cell cycle parameters to in vitro and in vivo chemosensitivity for a series of Lewis lung carcinoma lines.
    Holdaway KM; Finlay GJ; Baguley BC
    Eur J Cancer; 1992; 28A(8-9):1427-31. PubMed ID: 1515264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro.
    Finlay GJ; Baguley BC
    Eur J Cancer Clin Oncol; 1989 Feb; 25(2):271-7. PubMed ID: 2702982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of amsacrine.
    Baguley BC; Wilson WR
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):607-13. PubMed ID: 3653185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the cytotoxicity of amsacrine and its analogue CI-921 against cultured human and mouse bone marrow tumour cells.
    Ching LM; Finlay GJ; Joseph WR; Baguley BC
    Eur J Cancer; 1990 Jan; 26(1):49-54. PubMed ID: 2138478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokinetic resistance of Lewis lung carcinoma to cyclophosphamide and the amsacrine derivative CI-921.
    Baguley BC; Finlay GJ; Wilson WR
    Prog Clin Biol Res; 1986; 223():47-61. PubMed ID: 3809201
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytokinetic differences in the action of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide as compared with that of amsacrine and doxorubicin.
    Haldane A; Holdaway KM; Finlay GJ; Baguley BC
    Cancer Chemother Pharmacol; 1993; 32(6):463-70. PubMed ID: 8258195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivatives of amsacrine: determinants required for high activity against Lewis lung carcinoma.
    Baguley BC; Finlay GJ
    J Natl Cancer Inst; 1988 Apr; 80(3):195-9. PubMed ID: 3346911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.
    Twentyman PR; Bleehen NM
    Br J Cancer; 1976 Mar; 33(3):320-8. PubMed ID: 57788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation by phenylbisbenzimidazoles of cytotoxicity of anticancer drugs directed against topoisomerase II.
    Finlay GJ; Baguley BC
    Eur J Cancer; 1990; 26(5):586-9. PubMed ID: 1698074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, antitumor activity, and DNA binding properties of a new derivative of amsacrine, N-5-dimethyl-9-[(2-methoxy-4-methylsulfonylamino) phenylamino]-4-acridinecarboxamide.
    Baguley BC; Denny WA; Atwell GJ; Finlay GJ; Rewcastle GW; Twigden SJ; Wilson WR
    Cancer Res; 1984 Aug; 44(8):3245-51. PubMed ID: 6547635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental antitumor activity of the amsacrine analogue CI-921.
    Leopold WR; Corbett TH; Griswold DP; Plowman J; Baguley BC
    J Natl Cancer Inst; 1987 Aug; 79(2):343-9. PubMed ID: 3474465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plateau-phase cultures: an experimental model for identifying drugs which are bioactivated within the microenvironment of solid tumours.
    Phillips RM; Clayton MR
    Br J Cancer; 1997; 75(2):196-201. PubMed ID: 9010026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures.
    Rockwell S; Hughes CS
    Cell Prolif; 1994 Mar; 27(3):153-63. PubMed ID: 10465006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic activity of calcein acetoxymethyl ester (Calcein/AM) on primary cultures of human haematological and solid tumours.
    Jonsson B; Liminga G; Csoka K; Fridborg H; Dhar S; Nygren P; Larsson R
    Eur J Cancer; 1996 May; 32A(5):883-7. PubMed ID: 9081371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antitumor agents. 48. 3'-Dimethylamino derivatives of amsacrine: redox chemistry and in vivo solid tumor activity.
    Atwell GJ; Rewcastle GW; Baguley BC; Denny WA
    J Med Chem; 1987 Apr; 30(4):652-8. PubMed ID: 3560159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of the effects of aphidicolin and other inhibitors on topoisomerase II-directed cytotoxic drugs.
    Haldane A; Finlay GJ; Baguley BC
    Oncol Res; 1993; 5(3):133-8. PubMed ID: 8260750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new amsacrine derivative, N-5-dimethyl-9-(2-methoxy-4-methylsulfonylamino)phenylamino-4- acridinecarboxamide, on cultured mammalian cells.
    Traganos F; Bueti C; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1987 Jan; 47(2):424-32. PubMed ID: 2431770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.